Recent Press Releases

Early Successful Readout of Tarceva Study in a Distinct Form of Lung Cancer

-- EURTAC is the First Phase III Study to Show Progression-Free Survival Benefit of First-Line Tarceva in a Western Population with Advanced Lung Cancer With EGFR Mutations -- SOUTH SAN FRANCISCO,

Pfizer Announces HSR Clearance for the Acquisition of King Pharmaceuticals

All Conditions to Tender Offer Expected to Be Satisfied by Friday, January 28, 2011 Expiration Date NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the waiting period under

Verizon to Discuss Terremark Acquisition on Jan. 28

NEW YORK, Jan. 27, 2011 /PRNewswire/ -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will host a webcast on Friday, Jan. 28, to discuss the company's definitive agreement to acquire Terremark, a

Reportlinker Adds The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact

NEW YORK, Jan. 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis

REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011

CUPERTINO, Calif., Jan. 27, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today reported that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of the New Drug

Bristol-Myers Squibb Delivers Solid Fourth Quarter Results in a Year Highlighted by Robust Clinical Data, Continued Execut

Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth QuarterSubmits Dapagliflozin for Regulatory Review in U.S. and Europe in Fourth QuarterIncreases

Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team

Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team Dr. Hemant Misra Joins Prolong as VP, Manufacturing and Facilities

Mitsubishi Tanabe Pharma Starts Voluntary Recall of Injection Solution Products

TOKYO, Jan. 26 -- (Kyodo) -- Mitsubishi Tanabe Pharma Corp. on Wednesday initiated a voluntary recall of three injection solution products that one of its subsidiaries may have shipped without

Ohio Changes Lethal Injection Drug

Ohio Changes Lethal Injection Drug (Columbus) - The Ohio Department of Rehabilitation and Correction (DRC) announced today it will substitute Pentobarbital for Sodium Thiopental for the purposes of

DHL Station Receives Accreditation as Qualified Envirotainer Provider (QEP)

DHL Station Receives Accreditation as Qualified Envirotainer Provider (QEP)San Francisco added as a QEP Accredited stationDHL Global Forwarding's solutions driven expertise provides the Healthcare,

Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance

INDIANAPOLIS, Jan. 27, 2011 /PRNewswire/ --Higher volume drove four percent revenue growth in Q4.Gross margin improvements in Q4 led to growth in operating income.Fourth quarter earnings per share

FDA Advisory Committee Votes Favorably on Expanding the Indication for Abbott's Carotid Stent System to Include Patients at Stan

ABBOTT PARK, Ill., Jan. 26, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory

Teva to Acquire Corporación Infarmasa

Acquisition Will Expand Teva’s Footprint in Latin America JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today the acquisition of Corporación Infarmasa, a

TEVA TO ACQUIRE CORPORACIÓN INFARMASA

TEVA TO ACQUIRE CORPORACIÓN INFARMASAAcquisition Will Expand Teva's Footprint in Latin America -- Jerusalem, Israel, January 26, 2011 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA)

Blue Cross and Blue Shield of Georgia Urges Seniors to Get Flu and Pneumonia Vaccines

For older adults, the seasonal flu can be very serious, even deadlyATLANTA, Jan. 26, 2011 /PRNewswire/ -- The seasonal flu can be very serious for everybody. So serious, in fact, that the Centers for

For the Treatment of Epilepsy, the Highest Percentage of Surveyed Neurologists and MCOs Identified UCB’s Keppra as the The

However, Surveyed Neurologists Are Only Moderately Satisfied With Keppra’s Accessibility, According to Findings from Decision Resources BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision Resources, one of

Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Ongoing Earnings Outlook for 2011

Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Ongoing Earnings Outlook for 2011Date: January 26, 2011   Worldwide Sales Increased 13.4 PercentFourth

U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use

U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use-- Allegra® family of products to be available without a prescription across the U.S. this